Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
GHRH Analog (Short-Acting)
Weekly Protocol Guide
CJC-1295 without DAC Protocol Guide
⚠ No validated human dose. This compound is not FDA-approved and has no peer-reviewed human dose-finding trials. The figures below are research conventions extrapolated from preclinical (animal/in‑vitro) and community sources — not validated clinical dosing. Treat them as study references only. Research use only; not medical advice.
CJC-1295 without DAC (also known as Mod GRF 1-29) is a short-acting GHRH analog with a half-life of approximately 30 minutes. It stimulates pulsatile GH release from the pituitary. Best administered before bed to synergize with natural nocturnal GH pulses. This is a solo protocol, NOT a blend.
Protocol Overview
- Compound
- CJC-1295 without DAC (Modified GRF (1-29) / Mod GRF 1-29)
- Category
- GHRH Analog (Short-Acting)
- Vial Size
- 2mg (2,000mcg)
- Reconstitution
- 2mL bacteriostatic water (1mg/mL)
- Route
- Subcutaneous injection
- Frequency
- 7 days/week
Reconstitution Instructions
Using 2mL of bacteriostatic water results in a concentration of 1mg/mL. Always use sterile techniques.
Materials Needed
- 2mg CJC-1295 without DAC 2mg vial (lyophilized powder)
- 2mL bacteriostatic water (sterile, preserved with 0.9% benzyl alcohol)
- Sterile syringe and needle (18-22 gauge for drawing)
- Alcohol swabs
- Clean workspace
Step-by-Step Process
- Preparation: Allow the CJC-1295 without DAC 2mg vial and bacteriostatic water to reach room temperature. Wipe the rubber stoppers of both vials with an alcohol swab.
- Draw the Water: Using a sterile syringe, draw up exactly 2mL of bacteriostatic water. Expel any air bubbles.
- Inject into Vial: Insert the needle through the rubber stopper at a slight angle, aiming toward the glass wall. Slowly inject the water down the side of the vial to avoid foaming.
- Mix Gently: Remove the needle. Gently swirl or roll the vial between your hands. Do not shake vigorously.
- Check for Clarity: The solution should be clear once fully reconstituted. Do not use if cloudy.
Weekly Dosing Reference · research convention, not a validated dose
| Day | Units | Dose | Timing |
|---|---|---|---|
| Monday | 10 | 100mcg | Before bed |
| Tuesday | 10 | 100mcg | Before bed |
| Wednesday | 10 | 100mcg | Before bed |
| Thursday | 10 | 100mcg | Before bed |
| Friday | 10 | 100mcg | Before bed |
| Saturday | 10 | 100mcg | Before bed |
| Sunday | 10 | 100mcg | Before bed |
Weekly Total: 70 units (700mcg) • Vial Duration: ~20 days
Quick Dosing Reference · research convention, not a validated dose
| Units (Ticks) | Dose (mcg) | Dose (mg) |
|---|---|---|
| 5 | 50 | 0.05mg |
| 10 | 100 | 0.1mg |
| 20 | 200 | 0.2mg |
| 50 | 500 | 0.5mg |
| 100 | 1000 | 1mg |
Administration Guidelines
- Administer subcutaneously before bed on an empty stomach (2+ hours after eating)
- ~30 minute half-life requires daily dosing for best results
- Rotate injection sites between abdomen, thigh, and upper arm
- Can be combined with a GHRP for synergistic GH release
- Store reconstituted peptide refrigerated at 36-46F (2-8C)
- Use reconstituted solution within 30 days
- Never freeze reconstituted peptides
- Document administration times and observations
Storage Requirements
| State | Storage Conditions |
|---|---|
| Lyophilized (powder) | Room temperature or refrigerated, protect from light |
| Reconstituted | Refrigerated 36-46F (2-8C), use within 30 days |